Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load.
about
Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Long-term efficacy and safety ...... with undetectable viral load.
@en
Long-term efficacy and safety ...... with undetectable viral load.
@nl
type
label
Long-term efficacy and safety ...... with undetectable viral load.
@en
Long-term efficacy and safety ...... with undetectable viral load.
@nl
prefLabel
Long-term efficacy and safety ...... with undetectable viral load.
@en
Long-term efficacy and safety ...... with undetectable viral load.
@nl
P2093
P2860
P50
P1433
P1476
Long-term efficacy and safety ...... with undetectable viral load.
@en
P2093
Alba Bigoloni
Andrea Poli
Daniela Mancusi
Elisabetta Carini
Giuseppe Tambussi
Laura Galli
Nicola Gianotti
Roberta Termini
Silvia Nozza
P2860
P304
P356
10.1371/JOURNAL.PONE.0191300
P407
P577
2018-02-16T00:00:00Z